To Elucidate the Effect of Mesenchymal Stem Cells on the T Cell Repertoire of the Kidney Transplant Patients
A Randomized Trial to Elucidate Effect of Mesenchymal Stem Cells on Immune Modulation in Living Related Kidney Transplant Patients
Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh
A PHASE1 clinical study on Renal Transplant Rejection, this trial is ongoing. The trial is conducted by Post Graduate Institute of Medical Education and Research, Chandigarh and has accumulated 8 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Jul 2025 — Present [monthly]
Unknown PHASE1
-
Sep 2024 — Jul 2025 [monthly]
Unknown PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE1
Status: Unknown Status → Unknown
-
Apr 2024 — Jul 2024 [monthly]
Unknown Status PHASE1
-
Jan 2021 — Apr 2024 [monthly]
Unknown Status PHASE1
▶ Show 3 earlier versions
-
Dec 2018 — Jan 2021 [monthly]
Unknown Status PHASE1
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — Dec 2018 [monthly]
Active Not Recruiting PHASE1
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE1
First recorded
Sep 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Post Graduate Institute of Medical Education and Research, Chandigarh
For direct contact, visit the study record on ClinicalTrials.gov .